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Abstract ApneaGraph relies on measuring pressure and
airXow simultaneously at diVerent levels in the pharynx
identifying the segment of airway obstruction and provid-
ing baseline respiratory parameters. This study aims to
evaluate ApneaGraph and correlate results with both sleep
nasendoscopy and polysomnography. This was a prospec-
tive study of 49 patients with snoring and/or obstructive
sleep apnoea. Thirty of the these patients underwent a PSG
and an ApneaGraph study simultaneously in the Sleep Lab.
Nineteen patients attended the day surgery unit and had a
sleep nasendoscopy with a 10-min ApneaGraph analysis.
Polysomnography was used to validate the ApneaGraph
system. There are no signiWcant diVerences (independent t
test, P > 0.15) between ApneaGraph compared to Polysom-
nography based on the apnoea–hypopnoea index, total
number of apnoeic events, average oxygen saturations and
maximum desaturation. This suggests that the ApneaGraph
can be used to assess OSA. Statistically, there is poor corre-
lation between the two groups (Spearman’s  0.29). In the
cases of discordance, ApneaGraph places greater emphasis
on a lower pharyngeal contribution. This unique study anal-
yses the ApneaGraph system in the diagnosis of obstructive
sleep apnoea and snoring. It demonstrates the beneWts of
this new system and highlights certain limitations in local-
izing the site and level of pharyngeal obstruction in patients
with sleep disorders.
Keywords Obstructive sleep apnoea · Snoring · 
Sleep nasendoscopy · Polysomnography
Introduction
Sleep-related breathing disorders (SRBD) aVect 1–4% of
the population [1] causing daytime somnolence, impaired
work performance, increased road traYc incidents, hyper-
tension and ischaemic heart disease [2, 3]. It is classically
diagnosed by the in-laboratory overnight polysomnography
(PSG) sleep study [4]. However, the limited number of
sleep centres and beds often results in long-waiting lists for
diagnosis and treatment of SRBD. There is evidence that
untreated sleep apnoea is both deleterious to the patient and
expensive to the healthcare budget [5, 6].
The AG200 ApneaGraph system (MRA, Medical, UK) is
a relatively newer technology designed for the evaluation of
SRBD. It stores and analysis the cardio-respiratory pattern of
a patient with simultaneous recording of two diVerent sites in
the upper airway using a micro-pressure and temperature
transducer catheter. By measuring pressure and airXow (via
temperature) simultaneously in the pharynx, it is possible to
identify the segment of obstruction during sleep in patients
with upper airway obstructions (apnoea, hypopnoea and
snoring). Previous work has shown that the use of continuous
airway pressure and Xow monitoring is repeatable [7] and
reproducible between ambulatory and hospital settings [8].
Potentially, the ApneaGraph system could replace home
sleep studies and sleep nasendoscopy (SNE), as it can pro-
vide an equivalent level of information, implying a signiW-
cant cost-saving. It is also more portable with less
connections compared to some other devices. However, the
quality of information gathered from ApneaGraph (AG)
and probe-related problems have not been evaluated.
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compared to full polysomnography and the current practise
of sleep nasendoscopy.
Methods
Patients awaiting an overnight sleep study based in the
sleep lab or a sleep nasendoscopy on the elective waiting
list were enrolled in to the study. Two groups were deWned:
the Wrst was a comparison of the studied device (Apnea-
Graph) with full PSG (Sleep acquisition computer, Oxford
Instruments, UK) in a dedicated sleep lab over a 6-h period
and the second included a synchronous recording of Apnea-
Graph with sleep nasendoscopy over a 10-min period.
The AG system does not require thoracic or abdominal
pressure transducer bands, making it easier to apply to the
patient. A pulse oximetry probe is attached to the Wnger and
a Wne-bore catheter inserted into the nose and placed in the
upper oesophagus, similar to a naso-gastric tube (see
Fig. 1). There are four transducers (two pressure and two
temperature) with one marker probe positioned at the lower
border of the soft-palate (see Fig. 2), this ensures that all
transducers are correctly aligned. The device can be pre-
programmed to start at a set time and record for a maximum
of 6 h. Data can then be downloaded and analyzed using
dedicated software (Apnea Analysis version 6.61, MRA).
All patients were recruited from the sleep clinic at the
Royal National Throat, Nose and Ear Hospital, London.
Inclusion criteria included a history of snoring or possible
OSA with patients having provided informed consent to
participate in the study. The exclusion criteria included
patients with: body mass index (BMI) >33 kg/m2, requiring
CPAP, ishaemic heart disease or previous treatment for
SRBD.
Patients attending for overnight PSG were managed in
the usual way by a dedicated nurse and had the AG system
attached, in addition to the standard equipment. Indepen-
dent printed reports were provided for PSG and the AG
analyses. For patients attending for SNE, the AG catheter
was placed with the patient awake and the marker probe
checked for position. These patients would then undergo
SNE in the usual way. The surgeon would grade the levels
of pharyngeal obstruction and record them on a proforma.
The data from AG were not analyzed at the same time and
sent to an independent assessor blinded to the results of
SNE to reduce bias.
Ethical approval for this study was provided by the local
research and ethics committee.
Data were analyzed using SPSS software (SPSS version
13, Chicago, IL). Age, BMI, Epworth sleepiness scores and
respiratory parameters (AHI, apnoeic and hypopnoeic
events, average oxygen saturation, maximum desaturation)
were treated as continuous variables with parametric analy-
sis (normal distribution veriWed using the Kolmogorov–
Smirnov test). All other data was considered ordinal and
Spearman’s  employed for correlation analysis.
Results:
Forty-nine patients (36 males and 13 females) participated
in the study with the following parameters (mean §
standard deviation): age 47.6 § 11.7 years, BMI 31.1
(§5.8) kg/m2, Epworth sleepiness score 10.5 § 5.8.
Thirty patients underwent an overnight PSG with a 4–
6 h AG study and 19 patients underwent a simultaneous
ApneaGraph and sleep nasendoscopy. Ten patients experi-
enced catheter displacement but seven patients had
obtained 4 h of recording and so their data were included in
Fig. 1 The ApneaGraph device with its components: a pulse oximetry
probe and the Wne-bore nasal catheter with four transducers
Fig. 2 Silver marker in the oropharynx denoting correct position of
ApneaGraph probe123
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unable to tolerate the naso-oesophageal probe due to dis-
comfort and no AG recording was possible. Therefore, the
total number of patients unable to provide an AG recording
(due to discomfort or displacement) was 26% (16/62).
AG versus PSG
PSG was used to validate the ApneaGraph system and the
mean values are shown in Table 1. There are no signiWcant
diVerences (independent t test, P > 0.15) between AG com-
pared to PSG based on the apnoea–hypopnoea index, total
number of apnoeic events, average oxygen saturations and
maximum desaturation. Hypopnoeic events did demon-
strate a signiWcant diVerence (67.4 versus 18.9 events,
P < 0.0001).
Both SNE and AG provide information on the levels of
pharyngeal obstruction and can be grouped into predomi-
nantly upper or predominantly lower pharyngeal obstruc-
tion. However, we prefer to reWne this further by looking at
percentage contribution of upper and lower pharyngeal seg-
ments to the overall pharyngeal obstruction [for example,
80% palatal obstruction (upper) and 20% tongue base
obstruction (lower)]. SNE percentage scores are based on
the senior author (BK) assessment. This same approach can
be applied to AG as it produces percentage obstruction gen-
erated from the recorded data. These results are summa-
rized in Table 2 and illustrated by Fig. 3, in which upper
pharyngeal obstruction is represented by bars above the
dotted line and implies a predominantly velopharyngeal
component to the SRBD.
Using Spearman’s rank, there is poor correlation
between SNE and AG based on the upper and lower per-
centage pharyngeal contribution to overall obstruction
( = 0.29). We also looked at agreement between the two
methods. In order to do this pragmatically, the Wndings
were translated into predominantly upper or predominantly
lower pharyngeal obstruction as shown in Table 3. Two
cases showed an equal upper and lower contribution (i.e.
mixed) on AG recording precluding them from further analy-
sis. On this basis, when AG predicts an upper pharyngeal
obstruction SNE agrees in all (7/7) the cases. Conversely,
when AG predicts a predominantly lower obstruction SNE
agrees in only 40% (4/10) of the cases. This suggests that
Table 1 Parameters compared using AG and PSG (standard devia-
tions in brackets)












PSG 18.3 (16.4) 59.3 (76.7) 67.4 (49.4) 95 (2.0) 82 (8.0)
AG 17.3 (16.7) 52.5 (46.9) 18.9 (27.9) 94 (2.0) 79 (10.0)
Table 2 Details of site of obstruction by percentage contribution of
upper and lower pharyngeal components
Case number AG SNE
Upper (%) Lower (%) Upper (%) Lower (%)
1 80 20 30 70
2 80 20 20 80
3 70 30 70 30
4 100 0 50 50
5 100 0 70 30
7 80 20 20 80
8 100 0 10 90
9 65 35 20 80
10 60 40 40 60
11 100 0 80 20
12 40 60 20 80
13 60 40 95 5
14 80 20 90 10
15 20 80 40 60
16 75 25 50 50
17 40 60 40 60
18 75 25 90 10
19 10 90 20 80
Table 3 Details of the site of obstruction based on AG and SNE
U, predominantly upper; L, predominantly lower obstruction; M,
mixed
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Discussion
There is no statistically signiWcant diVerence between the
in-lab recording of ApneaGraph and polysomnography on
the basis of apnoea/hypopnoea index, apnoeic events, oxy-
gen saturations and maximum desaturation.
Hypopnoeic events did diVer signiWcantly and may be
explained by the diVerent technologies. Obstructive hypop-
noea is deWned as a decrease in airXow to less than 50%
baseline amplitude for a minimum of two respiratory cycles
or an abnormal respiratory event lasting >10 s with a smaller
reduction in airXow amplitude, but with an associated
arousal or desaturation. Methods for the measurement of
hypopnoea are related to the ability of a particular method to
detect the presence of a hypopnoea. Criteria for measuring
hypopnoeas have varied widely [9] AG utilises oesophageal
pressure, which is considered to be a reliable way of assess-
ing Xow changes. This contrasts with PSG, in which, reduc-
tion in airXow is detected by the nasal cannula and
corroborated with changes in respiratory rate and heart rate.
Previous work has shown that pressure recordings pro-
vide comprehensive diagnostic information in SRBD [10].
The AG device, in the diagnosis of OSA, compares favour-
ably with polysomnography. Importantly, the addition of
AG to patients having PSG does not signiWcantly aVect
respiratory parameters [11].
In ascertaining the level of the pharyngeal obstruction,
we found that AG and SNE had signiWcant discordance
suggesting diVerent interpretations are provided. Neither is
an agreed standard for the evaluation of upper pharyngeal
collapse and not unsurprisingly there is poor correlation
between the two diVerent technologies. This does not mean
that either technology is inappropriate for assessment. In
fact, we believe, that both methods used in conjunction may
have a role to play. The authors feel that the absence of
direct dynamic visualization, as provided by SNE, limits
information gathered on sites of obstruction especially in
the lower pharyngeal tract.
If AG predicts an upper site of obstruction there is a
high chance that SNE Wndings would agree. In contrast,
of the lower cases of obstruction predicted by AG, less
than half were conWrmed by SNE. This Wnding raises the
possibility of using AG as a screening tool. If we perform
AG instead of the current home-based sleep study we
should get reliable information on their AHI parameter
and some idea of the site of obstruction. Our results sug-
gest that upper obstruction is better correlated between
AG and SNE but discrepancies arise when AG makes a
diagnosis of lower obstruction. So, If AG reports an upper
problem we could go on and oVer a management plan for
upper pharyngeal collapse (for example, a mandibular
advancement device or palatal surgery). If AG reports a
lower problem then these patients need to undergo SNE to
further evaluate their lower pharyngeal airway and then
formulate appropriate treatment options. This could help
streamline services and may save in costs in the long
term.
Flowchart demonstrating role of AG in evaluation of
SRBD:
All patients have home AG
Fig. 3 Bar chart showing the 
percentage upper obstruction 
based on SNE and AG record-
ings. Bars above the dotted line 
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or palatal surgery
• mainly lower obstruction!proceed to SNE!formulate
treatment plan
The ApneaGraph system is applicable in the sleep state as
well as the sedation state (i.e. as in sleep nasendoscopy).
However, even in our limited analysis, the acquisition of
data in these two diVerent states is performed over diVerent
time periods making any comparison inappropriate.
There is no test/investigation that is the gold standard, to
determine the degree and site of pharyngeal obstruction in
the evaluation of SRBD. Therefore, we have no way of
knowing which test (AG or SNE) is more accurate. Both
modalities have their advantages and disadvantages; SNE is
minimally invasive and provides a dynamic visualization of
pharyngeal collapse but is operator dependent and requires
sedation; AG does not need sedation and combines the
sleep study with data on site of obstruction in one investiga-
tion but is poorly tolerated by some patients and relies on
accurate placement and limited respiratory movement arte-
fact. During the SNE part of our study, we noted that the
AG catheter moved with respiration and often required
repositioning endoscopically due to probe displacement.
Further, the microtransducers are all at Wxed distances but
morphological variations in pharyngeal dimensions may
prevent appropriate placement of the transducers. We note,
from the literature, that over the last 10 years three diVerent
systems have been described varying the number of trans-
ducers and the distances between them. In restricted oro-
pharyngeal views it was diYcult to know which transducer
was being visualized and which direction the catheter need
to be adjusted in order to see the marker. We felt that using
diVerent colour transducers would be extremely helpful in
obtaining accurate positioning and are aware that this tech-
nique was employed in an early study [12].
The high number of patients unable to tolerate the AG
catheter diVers from the impression gleaned from the previ-
ous studies. Generally, patients felt that the insertion of the
probe caused discomfort and some found it an eye-watering
experience. Initially, catheter displacement was attributed
to problems with the Wxation of the probe to the nose. How-
ever, the actual tape used remained attached to the nose and
it was the distal probe which had become displaced. One
possibility which may explain the discomfort levels is that
the transducers add stiVness to the catheter making it less
tolerable then an ordinary Wne-bore nasogastric tube.
In our practise, we do not feel that AG can replace SNE
but it is, nevertheless, a welcome addition to our armamen-
tarium in the evaluation of SRDB. In cases where both AG
and SNE were to agree in their Wndings then this may lend
greater support in the subsequent management. If disagree-
ment occurs between the two tests then we would favour
the Wndings of SNE; as we feel dynamic, three-dimen-
sional, real time evaluation of the anatomical sites of upper
airway collapse remains invaluable. Further, SNE allows
detailed assessment of the lower aerodigestive tract includ-
ing the tongue base, epiglottis and larynx which is not
available with AG.
The Wndings of the study are interesting and certainly
commend that AG be further evaluated. It is reliable as a
home sleep study providing an accurate measure of
apnoeic/hypopnoeic events and pulse oximetry. Secondly,
it provides an insight into the level of obstruction but needs
further evaluation before it can be relied upon in the deci-
sion-making process for SRDB. The sophisticated use of
both AG and SNE in the evaluation of multi-segmental
obstruction may allow us to provide a better tailored solu-
tion for the patient eventually leading to a more successful
outcome. For example, if SNE predicts a predominant
upper level of obstruction but AG diVers, then this may
suggest that the patient needs to have both upper and lower
segments addressed to improve symptoms. Clearly, to clar-
ify this intriguing concept further studies are needed.
Conclusion
Our results and experience reaYrm the need for polysom-
nography and sleep nasendoscopy in the multidimensional
evaluation of upper airway obstruction in SRBD. The
ApneaGraph is a diVerent technology which is potentially
exciting but poorly tolerated by some and requires further
evaluation to ascertain the reliability of data regarding
upper and lower pharyngeal obstruction.
Acknowledgments We wish to thank Maria Heraldo, Robert Roy-
ston, Dr. Jane Williams, Anna Smits and Regina Conradt for their
excellent support in helping to complete this study.
Open Access This article is distributed under the terms of the Crea-
tive Commons Attribution Noncommercial License which permits any
noncommercial use, distribution, and reproduction in any medium,
provided the original author(s) and source are credited.
References
1. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badar S (1993)
The occurrence of sleep-disordered breathing among middle-aged
adults. N Engl J Med 328:1230–1235
2. Teran-Santos J, Jimenez-Gomez A, Cordero-Guevara J (1999) Co-
operative Group Burgos Santander. The association between sleep
apnoea and the risk of traYc accidents. N Engl J Med 340:847–851
3. Nieto FJ, Young TB, Lind BK et al (2000) Association of sleep-
disordered breathing, sleep apnoea and hypertension in a large
community-based study Sleep Heart Health Study. JAMA
283:1829–1836
4. American Academy of Sleep Medicine Task Force Report (1999)
Sleep-related breathing disorders in adults: recommendations for123
1494 Eur Arch Otorhinolaryngol (2008) 265:1489–1494syndrome deWnition and measurement techniques in clinical re-
search. Sleep 22:667–689
5. Kapur V, Blough DK, Sandblom RE et al (1999) The medical cost
of undiagnosed sleep apnoea. Sleep 22:749–755
6. Bahammam A, Deaive K, Ronald J, Manfreda J, Ross L, Kryger
MH (1999) Health care utilization in males with obstructive sleep
apnoea syndrome two years after diagnosis and treatment. Sleep
22:740–747
7. Rollheim J, Tvinnereim M, Sitek J, Osnes T (2001) Repeatability
of sites of sleep-induced upper airway obstruction. A 2-night study
based on recordings of airway pressure and Xow. Eur Arch Otorh-
inolaryngol 258:259–264
8. Rollheim J, Osnes T, Miljeteig H (1999) The sites of obstruction
in OSA, identiWed by continuous measurements of airway pressure
and Xow during sleep: ambulatory versus in-hospital recordings.
Clin Otolaryngol 24(6):502–506
9. Moser NJ, Phillips BA, Berry DT, Harbison L (1994) What is
hypopnea, anyway? Chest 105:426–428
10. Tvinnereim M, Cole P, Haight JSJ, HoVstein V (1995) Diagnostic
airway pressure recording in sleep apnea syndrome. Acta Otolar-
yngol 115:449–454
11. Skatvedt O, Akre H, Godtlibsen OB (1996) Nocturnal polysom-
nography with and without continuous pharyngeal and esophageal
pressure measurements. Sleep 19(6):485–490
12. Tvinnereim M, Milijeteig H (1992) Pressure recordings—a meth-
od for detecting site of upper airway obstruction in obstructive
sleep apnea syndrome. Acta Otolaryngol 492S:132–140123
